6006
Z.-L. Yuan et al. / Tetrahedron 65 (2009) 6001–6007
(EI) calcd for C18H14F3NO2 (MþHþ): 333.0977, found: 333.0981.
J¼1.5 Hz, CH), 6.03 (dd, 1H, J¼6.0, 2.1 Hz, CH), 6.50 (d, 2H, J¼7.5 Hz,
ArH), 6.72 (t, 1H, J¼7.2 Hz, Ar), 7.09–7.19 (m, 3H, ArH), 7.32 (d, 1H,
J¼8.4 Hz, ArH), 7.37 (d, 1H, J¼2.1 Hz, Ar), 7.52 (dd, 1H, J¼5.7, 1.2 Hz,
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H
column(hexane/iPrOH¼90:10,0.7 mL/min, 230 nm, tminor¼8.63 min,
20
tmajor¼13.28 min; [
a
]
ꢀ80.8 (c 2.10, CH2Cl2), 65% ee).
CH). 13C NMR (75 MHz, CDCl3, TMS):
d 54.8, 83.9, 113.5, 118.9, 123.5,
D
127.9, 129.3, 129.4, 129.6, 132.2, 133.9, 134.7, 145.1, 151.9, 171.8. MS
(EI) m/e 333 [Mþ] (2.0), 254 (11.1), 252 (63.2), 250 (100), 214 (10.9),
152 (5.5), 104 (24.2), 93 (3.6), 77 (38.5). HRMS (EI) calcd for
C17H13Cl2NO2 (MþHþ): 333.0323, found: 333.0318. Enantiomeric
excess was determined by HPLC with a Chiralcel OD-H column
3.3.5. (S)-5-((R)-(4-Bromophenyl)(4-bromophenylamino)-
methyl)furan-2(5H)-one (3e)
A pale yellow solid, mp 147–152 ꢁC. IR (CH2Cl2):
n
3371, 3032,
2970, 2925, 2372, 2351,1744,1594,1489,1366,1229,1217,1160,1092,
1073, 1010, 901 cmꢀ1. 1H NMR (300 MHz, CDCl3, TMS):
4.44 (1H, d,
d
(hexane/iPrOH¼80:20, 1.0 mL/min, 254 nm, tminor¼16.36 min,
20
J¼6.9 Hz, NH), 4.78 (1H, dd, J¼0.9, 6.9 Hz, CH), 5.43 (1H, ddd, J¼0.9,
1.2,1.8 Hz, CH), 6.09 (1H, dd, J¼1.8, 6.0 Hz, CH), 6.40 (2H, d, J¼9.0 Hz,
ArH), 7.15–7.21 (4H, m, ArH), 7.34 (1H, dd, J¼1.2, 6.0 Hz, CH), 7.46 (2H,
tmajor¼24.32 min; [
a]
ꢀ103.5 (c 1.05, CH2Cl2), 81% ee).
D
3.3.9. (S)-5-((R)-(4-Nitrophenyl)(phenylamino)methyl)-
furan-2(5H)-one (3i)
d, J¼8.4 Hz, ArH). 13C NMR (75 MHz, CDCl3, TMS):
d
58.8, 84.5, 110.6,
115.5,122.4,123.6,128.8,131.9,132.0,135.1,144.6,152.4,171.8. MS (EI)
m/e 421 [Mþ] (2.6), 343 (7.0), 342 (47.2), 340 (100), 338 (50.8), 184
(15.8), 115 (10.8), 89 (10.2), 76 (17.0). HRMS (EI) calcd for
C17H13Br2NO2 (MþHþ): 420.9313, found: 420.9308. Enantiomeric
excess was determined by HPLC with a Chiralcel OD-H column
A yellow oil. IR (CH2Cl2):
1759, 1602, 1519, 1437, 1347, 1319, 1278, 1254, 1160, 1104, 1045,
993 cmꢀ1. 1H NMR (300 MHz, CDCl3, TMS):
n 3378, 3107, 3053, 2923, 2847, 1929,
d
4.56 (1H, d, J¼7.2 Hz,
NH), 4.95 (1H, dd, J¼3.6, 7.2 Hz, CH), 5.48 (1H, ddd, J¼1.6, 2.0,
3.6 Hz, CH), 6.09 (1H, dd, J¼2.0, 5.6 Hz, CH), 6.52 (2H, d, J¼8.8 Hz,
ArH), 6.74 (1H, t, 7.6 Hz, ArH), 7.12 (2H, dd, J¼7.6, 8.8 Hz, ArH), 7.41
(1H, dd, J¼1.6, 5.6 Hz, CH), 7.51 (2H, d, J¼8.4 Hz, ArH), 8.17 (2H, d,
(hexane/iPrOH¼80:20, 1.0 mL/min, 254 nm, tminor¼21.62 min,
20
tmajor¼32.03 min; [
a
]
ꢀ111.2 (c 2.15, CH2Cl2), 62% ee).
D
J¼8.4 Hz, ArH). 13C NMR (75 MHz, CDCl3, TMS):
d 58.9, 84.3, 113.7,
3.3.6. (S)-5-((R)-(4-Bromophenylamino)(2-(trifluoro-
methyl)phenyl)methyl)furan-2(5H)-one (3f)
119.0, 123.5, 123.9, 128.4, 129.3, 144.3, 145.1, 147.7, 152.5, 171.6. MS
(EI) m/e 310 [Mþ] (7.0), 228 (15.5), 227 (100), 181 (42.3), 180 (17.5),
168 (7.7), 115 (7.3), 93 (12.7), 77 (24.3). HRMS (ESI) calcd for
C17H14N2O4 (MþHþ): 310.0954, found: 310.0952. Enantiomeric
excess was determined by HPLC with a Chiralcel AD-H column
A pale yellow oil. IR (CH2Cl2):
1764, 1697, 1594, 1491, 1453, 1401, 1310, 1276, 1251, 1164, 1118, 1074,
1036, 901 cmꢀ1 1H NMR (300 MHz, CDCl3, TMS):
4.45 (d, 1H,
n 3376, 3098, 2954, 2925, 2854,
.
d
J¼6.6 Hz, NH), 5.32 (dd, 1H, J¼7.8, 2.1 Hz, CH), 5.49 (d, 1H, J¼2.1 Hz,
CH), 6.09 (d, 1H, J¼3.9 Hz, CH), 6.48 (d, 2H, J¼8.1 Hz, ArH), 7.20 (d,
2H, J¼8.1 Hz, ArH), 7.38–7.45 (m, 2H, ArH), 7.51–7.62 (m, 2H, ArH),
(hexane/iPrOH¼80:20, 1.0 mL/min, 230 nm, tminor¼18.38 min,
20
tmajor¼24.23 min; [
a]
ꢀ92.7 (c 2.00, CH2Cl2), 59% ee).
D
7.71 (d, 1H, J¼6.9 Hz, CH). 13C NMR (75 MHz, CDCl3, TMS):
d
54.6,
3.3.10. (S)-5-((R)-(2-Methoxyphenylamino)phenylmethyl)-
furan-2(5H)-one (3j)
84.0, 110.9, 115.7, 123.7, 124.3 (q, J¼270 Hz), 126.6 (q, J¼5.3 Hz),
127.9, 128.2 (q, J¼30 Hz), 128.7, 132.7, 135.4, 144.3, 152.3, 171.7. 19F
A pale yellow solid, mp 143–146 ꢁC. IR (CH2Cl2):
n
3416, 3063,
2938, 2835,1762, 1600, 1512,1455,1430,1340,1245, 1222,1157, 1132,
1105, 1026, 896 cmꢀ1. 1H NMR (300 MHz, CDCl3, TMS):
3.87 (s, 3H,
NMR (CDCl3, 282 MHz, CFCl3):
d
ꢀ62.80. MS (EI) m/e 411 [Mþ] (4.7),
331 (15.3), 330 (89.3), 328 (100), 310 (56.8), 308 (58.8), 229 (39.6),
134 (16.9), 76 (24.9). HRMS (EI) calcd for C18H13BrF3NO2 (MþHþ):
411.0082, found: 411.0084. Enantiomeric excess was determined by
d
CH3), 4.85 (d,1H, J¼3.6 Hz, NH), 4.93 (d,1H, J¼5.1 Hz, CH), 5.45 (t,1H,
J¼2.1 Hz, CH), 6.11 (dd, 1H, J¼5.1, 1.5 Hz, CH), 6.37 (dd, 1H, J¼5.1,
1.5 Hz, CH), 6.63–6.78 (m, 3H, ArH), 7.26–7.34 (m, 5H, ArH), 7.39 (dd,
HPLC with a Chiralcel OD-H column (hexane/iPrOH¼90:10, 0.7 mL/
20
min, 230 nm, tminor¼21.33 min, tmajor¼30.93 min; [
a]
ꢀ65.5 (c
1H, J¼5.1, 1.5 Hz, CH). 13C NMR (75 MHz, CDCl3, TMS):
d 55.5, 59.2,
D
0.70, CH2Cl2), 55% ee).
85.4, 109.5, 111.3, 117.7, 120.9, 123.2, 127.1, 128.2, 128.8, 135.9, 137.1,
147.0, 153.0, 172.3. MS (EI) m/e 295 [Mþ] (2.6), 213 (17.0), 212 (100),
196 (17.5),134 (1.1),120 (33.6),115 (7.3), 91 (17.5), 77 (9.7). HRMS (ESI)
calcd for C17H14N2O4 (MþHþ): 295.1208, found: 295.1207. Enantio-
meric excess was determined by HPLC with a Chiralcel OD-H column
3.3.7. (S)-5-((R)-(4-Bromophenylamino)(2,4-dimethoxy-
phenyl)methyl)furan-2(5H)-one (3g)
A pale yellow oil. IR (CH2Cl2):
1744, 1605, 1591, 1502, 1455, 1365, 1293, 1263, 1229, 1216, 1207, 1158,
1090, 1034, 898 cmꢀ1. 1H NMR (300 MHz, CDCl3, TMS):
3.75 (s, 3H,
n 3727, 3375, 3025, 2970, 2840, 2346,
(hexane/iPrOH¼80:20, 1.0 mL/min, 254 nm, tmajor¼26.62 min,
20
d
tminor¼47.77 min; [
a
]
ꢀ85.8 (c 0.75, CH2Cl2), 63% ee).
D
CH3), 3.85 (s, 3H, CH3), 4.56 (d, 1H, J¼8.4 Hz, NH), 4.89 (t, 0.6H,
J¼1.5 Hz, CH, NH), 5.16 (dd, 1H, J¼8.1, 4.2 Hz, CH), 5.48 (t, 1H, J¼1.8 Hz,
CH), 5.99 (dd, 1H, J¼5.4, 1.8 Hz, CH), 6.16 (dd, 0.3H, J¼7.8, 1.8 Hz, CH),
6.37–6.44 (m, 4H, ArH), 7.07 (d, 1H, J¼8.4 Hz, ArH), 7.13 (d, 2H,
J¼8.7 Hz, ArH), 7.40 (dd, 1H, J¼5.7, 1.2 Hz, CH), 7.55 (dd, 0.3H, J¼5.7,
3.3.11. (R)-5-((S)-{4-Chlorophenyl-(diphenylphosphinoylamino)}-
methyl)-(5H)-furan-2-one (3k)
A white solid; this is a known compound.20 1H NMR (300 MHz,
CDCl3, TMS):
d
4.31 (dd,1H, J¼9.6, 6.6 Hz, NH), 4.54 (ddd,1H, J¼3.6, 3.6,
1.2 Hz, CH). 13C NMR (75 MHz, CDCl3, TMS):
d
52.7, 55.2, 55.4, 84.4,
10.8 Hz, CH), 5.56 (s, 1H, CH), 5.90 (d, 1H, J¼5.7 Hz, CH), 7.05 (d, 2H,
J¼8.4 Hz, ArH), 7.21 (d, 2H, J¼8.4 Hz, ArH), 7.36–7.54 (m, 7H, ArH and
CH), 7.69 (dd, 2H, J¼12.0, 7.8 Hz, ArH), 7.82 (dd, 2H, J¼12.0, 7.8 Hz, ArH).
Enantiomeric excess was determined by HPLC with a Chiralcel OD-H
98.4, 104.5, 109.7, 115.2, 115.7, 121.5, 122.6, 128.5, 131.8, 145.2, 153.3,
157.6, 160.6, 172.5. MS (EI) m/e 403 [Mþ] (0.7), 323 (18.0), 322 (99.2),
321 (20.4), 320 (100), 233 (12.1), 149 (14.8), 121 (12.9), 77 (6.1). HRMS
(EI) calcd for C19H18BrNO4 (MþHþ): 403.0419, found: 403.0424. En-
antiomeric excess was determined by HPLC with a Chiralcel OD-H
column (hexane/iPrOH¼90:10, 0.7 mL/min, 214 nm, tmajor¼24.15 min,
20
tminor¼32.21 min; [
a
]
þ13.5 (c 2.00, CHCl3), 43% ee).
D
column (hexane/iPrOH¼90:10, 0.7 mL/min, 230 nm, tminor¼44.13 min,
20
tmajor¼67.98 min; [
a
]
ꢀ100.1 (c 2.65, CH2Cl2), 80% ee).
Acknowledgements
D
3.3.8. (S)-5-((R)-(2,4-Dichlorophenyl)(phenylamino)methyl)-
furan-2(5H)-one (3h)
Financial support from the Shanghai Municipal Committee of
Science and Technology (06XD14005 and 08dj1400100-2), National
Basic Research Program of China (973)-2009CB825300, and the
National Natural Science Foundation of China (20872162,
20672127, 20732008, 20821002, and 20702013) are greatly
acknowledged.
A pale yellow oil. IR (CH2Cl2):
2320, 1753, 1602, 1561, 1504, 1470, 1453, 1384, 1316, 1229, 1217,
1158, 1103, 1043, 993 cmꢀ1. 1H NMR (300 MHz, CDCl3, TMS):
4.65
(d, 1H, J¼8.1 Hz, NH), 5.40 (dd, 1H, J¼5.4, 3.3 Hz, CH), 5.55 (t, 1H,
n 3377, 3089, 3054, 2924, 2847,
d